Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Ann Surg Oncol ; 29(9): 5699-5707, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-35653068

RESUMO

BACKGROUND: Both plasma fibrinogen level and neutrophil-to-lymphocyte ratio (NLR) are associated with malignant potential in different cancer types. The current study evaluated the use of combined plasma fibrinogen level and NLR (F-NLR) as a prognostic predictor in patients with non-small cell lung cancer (NSCLC). METHODS: Data collected from 279 patients with resectable NSCLC were retrospectively reviewed. Patients were divided into three groups based on the F-NLR score: score 2, high fibrinogen level (≥350 mg/dL) and high NLR (≥2.5); score 1, either high fibrinogen level or high NLR; and score 0, neither abnormal. Overall survival (OS) and relapse-free survival (RFS) were evaluated using the Kaplan-Meier method and log-rank test. Cox proportional hazard model was used to assess prognostic factors. RESULTS: Numbers of patients with F-NLR score of 0, 1, and 2 were 122 (43.7%), 105 (37.6%), and 52 (18.6%), respectively. The F-NLR was found to be significantly associated with age, male sex, heavy smoking history, high pT status and pathological stage, and nonadenocarcinoma. Moreover, the OS and RFS significantly differed according to the F-NLR score (P < 0.001, P = 0.003). A multivariate analysis revealed that a high F-NLR score (≥1) was an independent poor prognostic factor for OS (P = 0.027). In subgroup analyses, an adverse prognostic impact of the F-NLR score on OS was identified regardless of nodal involvement or pathological stage. CONCLUSIONS: The F-NLR score, which is based on histological inflammation and coagulability, could be a potential prognostic indicator in patients with resectable NSCLC.


Assuntos
Carcinoma Pulmonar de Células não Pequenas , Neoplasias Pulmonares , Carcinoma Pulmonar de Células não Pequenas/patologia , Fibrinogênio/metabolismo , Humanos , Neoplasias Pulmonares/patologia , Neoplasias Pulmonares/cirurgia , Linfócitos/patologia , Masculino , Recidiva Local de Neoplasia/patologia , Neutrófilos/patologia , Prognóstico , Estudos Retrospectivos
2.
Thorac Cancer ; 12(21): 2953-2955, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34590425

RESUMO

We report a case of an anticoagulated patient with sudden onset pleural hematoma after straining at defecation to cardiac arrest on 2 weeks after lobectomy for lung cancer. We decided to perform an emergent operation for an evacuation of extrapleural hematoma immediately after resuscitation. The bleeding point was revealed on the extrapleural thoracic apex. We should be aware that extrapleural hematoma can occur because of increased intrathoracic pressure such as straining during defecation in patients on anticoagulation.


Assuntos
Hematoma/cirurgia , Heparina/uso terapêutico , Neoplasias Pulmonares/cirurgia , Doenças Pleurais/cirurgia , Pneumonectomia/métodos , Complicações Pós-Operatórias/cirurgia , Pirazóis/uso terapêutico , Piridonas/uso terapêutico , Idoso de 80 Anos ou mais , Anticoagulantes/uso terapêutico , Defecação , Inibidores do Fator Xa/uso terapêutico , Hematoma/etiologia , Humanos , Masculino , Neoplasias de Células Escamosas/cirurgia , Doenças Pleurais/etiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...